Clinical Trials Logo

Hypoxic Encephalopathy clinical trials

View clinical trials related to Hypoxic Encephalopathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05785481 Active, not recruiting - Clinical trials for Hypoxic Encephalopathy

Early Neurological Outcome in Newborns With Mild Encephalopathy:a Regional Network

Start date: February 27, 2020
Phase:
Study type: Observational

This is a multicenter prospective observational study that aims to determine the natural history of patients with early diagnosis (within 6 hours of life) of mild hipoxic ischemic encephalopaty (HIE), who are not candidates for treatment with therapeutic hypothermia. The goal of this study is to learn about the early neurological outcome in babies with mild encephalopathy, as recent studies have shown how there is an increased risk of brain damage with a high incidence of resonance magnetic nuclear (RMN) anomalies and possible neurodevelopmental complications including learning or neuropsychological disorders, epilepsy, visual and sensory deficits. The main question aimed to answer is the identification of early possible predictive factors for an unfavorable outcome in order to undertake early rehabilitation programs and for the future planning of trials on early neuroprotection in the investigated population. Babies with early diagnosis (within 6h of life) of mild grade HIE not candidate for hypothermic treatment are subjected to clinical and instrumental assessments during the neonatal period: - neurological objective exam according to the modified "Sarnat" score, Thompson score and Hammersmith Neonatal Neurological Examination (HINE) within 6 hours of life, 24 hours of life and before resignation; - an Amplitude Electroencephalogram (aEEG) study within 6 hours of life, for 6 hours; - cerebral ultrasound within 6 hours of life, in the third and seventh day of life; - a brain magnetic resonance imaging study between the seventh and 14th day of life; - an Electroencephalogram (EEG) evaluation within 7 days. After resignation, all patients will be included in a minimum duration follow-up program of 12 months, with assessments at 3rd, 6th and 12th month of age: - Hammersmith Neonatal Neurological Examination (HINE) and evaluation of the General Movements; - evaluation of psychomotor development through Griffiths/Bayley III scales at the 12th month; - EEG evaluation at the 6th and 12th month.

NCT ID: NCT05652738 Completed - Clinical trials for Neonatal Encephalopathy

Passive Cooling Versus Blanket-Roll III on The Myocardial Function of Asphyxiated Neonates

Start date: January 20, 2022
Phase: N/A
Study type: Interventional

Studying the effect of passive versus Blanket roll III modality of therapeutic hypothermia (TH)on myocardial function of asphyxiated neonates through using tissue Doppler (TD).

NCT ID: NCT01920347 Completed - Clinical trials for Hypoxic Encephalopathy

The Neurological Pupil Index (NPi) on Intensive Care Unit (ICU) Trial

NPI-ON-ICU
Start date: May 2013
Phase: N/A
Study type: Observational

The trial will evaluate the use of the "Neurological Pupil index" NPi, measured with the digital pupillometer (NeurOptics) compared to clinical examination for better reliability. The investigators hypothesize that digital evaluation will offer a higher sensitivity/ specificity compared to clinical examination.